As filed with the Securities and Exchange Commission on August 25, 2021June 2, 2022

Registration No. 333-256636333-            

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON,Washington, D.C. 20549

 

 

AMENDMENT NO. 1 TO

FORM S-3

REGISTRATION STATEMENT UNDER

UNDER

THE SECURITIES ACT OF 1933

 

 

Meta Materials Inc.META MATERIALS INC.

(Exact name of registrant as specified in its charter)

 

 

 

Nevada 74-3237581

(State or other jurisdiction of

incorporation or organization)

 

(IRSI.R.S. Employer

Identification No.)

1 Research Drive
Dartmouth, Nova Scotia
B2Y 4M9
(Address of Principal Executive Offices)(Zip Code)Number)

1 Research Drive

Dartmouth, Nova Scotia B2Y 4M9

(902) 482-5729

(Address, including zip code, and telephone number, including area code of registrant’s principal executive offices)

 

 

George Palikaras

President

Meta Materials Inc.

1 Research Drive

Dartmouth, Nova Scotia B2Y 4M9

(902) 482-5729

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

Martin J. Waters

Tom Hornish

Wilson Sonsini Goodrich & Rosati, P.C.Professional Corporation

1233512235 El Camino Real

San Diego, CA 92130

(858) 350-2300

 

 

Approximate date of commencement of proposed sale to the publicpublic:: From time to time after thisthe effective date of the registration statement becomes effective.statement.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box:box.  ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box:box.  ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:offering.  ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:offering.  ☐

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box:box.  ☐

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box:box.  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer 
Non-accelerated filer   Smaller reporting company 
Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.Act  ☐

 

 

 


The information in this prospectus is not complete and may be changed. The selling stockholders may not sell these securities or accept an offer to buy these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities, and it is not soliciting offers to buy these securities in any state where such offer or sale is not permitted.

LOGO

Up to 190,900,700SUBJECT TO COMPLETION, DATED JUNE 2, 2022

PROSPECTUS

LOGO

9,677,419 Shares

of Common Stock

 

 

This prospectus relatescovers the offer and resale from time to time of up to 9,677,419 shares (the “Shares”) of our common stock, par value $0.001 per share, of Meta Materials Inc., a Nevada corporation (the “Company”), by the selling stockholders identified in this prospectus, including their transferees, pledgees or donees or their respective successors. The Shares offered by the selling stockholders consist of 9,677,419 shares of common stock that wewere privately issued pursuant to that certain Agreement for the Sale and Purchase of the Entire Issued Share Capital of Plasma App Ltd. (the “Acquisition Agreement”), by and among the Company, Dmitry Yarmolich and Dzianis Yarmolich, dated as of March 31, 2022 (the “Acquisition”). As a result of the Acquisition, the Company acquired Plasma App Ltd., a private company limited by shares incorporated in England and Wales.

The selling stockholders identified in this prospectus may issue,offer the shares of common stock pursuant to this prospectus from time to time upon exchange, retractionthrough public or redemptionprivate transactions at fixed prices, at market prices prevailing at the time of exchangeablesale, at prices related to prevailing market prices or at privately negotiated prices. The selling stockholders may sell shares to or through underwriters, broker-dealers or agents, who may receive compensation in the form of discounts, concessions or commissions from the selling stockholders, the purchasers of the shares, or both. For additional information on the methods of sale that may be used by the selling stockholders, see the section entitled “Plan of Distribution” on page 9. For a list of the selling stockholders, see the section entitled “Selling Stockholders” on page 8.

We are not selling any shares of Metamaterial Exchangeco Inc., a wholly-owned Canadian subsidiarycommon stock under this prospectus and will not receive any proceeds from the sale by the selling stockholders of ours that is referred to insuch shares. We are paying the cost of registering the shares of common stock covered by this prospectus as “Exchangeco.” We referwell as various related expenses. The selling stockholders are responsible for all selling commissions, transfer taxes and other costs related to the exchangeable sharesoffer and sale of Exchangeco as the “exchangeable shares”their shares.

You should carefully read this prospectus and to Meta Materials Inc. as “Meta.”any amendments or supplements accompanying this prospectus, together with any documents incorporated by reference herein or therein, before you make your investment decision.

The exchangeable shares were issued by Exchangeco in connection with our acquisition (the “Arrangement”) ofselling stockholders may sell any, all or none of the issued and outstanding common shares of Metamaterial Inc. (“Metamaterial”) to Metamaterial shareholders who made a valid election to receive exchangeable shares of Exchangeco in lieu of receiving shares of our common stock. The issuance of the exchangeable shares was not registered under the Securities Act of 1933, as amended (the “Securities Act”), and was issued in reliance upon the exemption from registration provided by section 3(a)(10) of the Securities Act on the basis of the approval of the Ontario Superior Court of Justice. Each exchangeable share may be exchanged at the election of the holder for one share of our common stock. In addition, under certain circumstances, Exchangeco can redeem the exchangeable shares in exchange for shares of our common stock on a one-for-one basis.

Because the shares of our common stocksecurities offered by this prospectus, will be issued onlyand we do not know when or in exchange for or upon retraction or redemptionwhat amount the selling stockholders may sell their common shares hereunder following the effective date of the exchangeable shares, we will not receive any cash proceeds fromregistration statement of which this offering. We are paying all expenses of registration incurred in connection with this offering.prospectus forms a part.

Meta’sOur common stock is listed on the Nasdaq Stock Market LLC, or Nasdaq, under the symbol “MMAT.” On May 31, 2022, the last reported sale price of our common stock was $1.92 per share.

 

 

Investing in our common stocksecurities involves a high degree of risk. Please read carefully the section entitledSeeRisk Factors” on page 25 of this prospectus and in the information included anddocuments incorporated by reference in this prospectus.prospectus, as updated by any applicable prospectus supplement, and other future filings we make with the Securities and Exchange Commission that are incorporated by reference into this prospectus, for a discussion of the factors you should consider carefully before deciding to purchase our securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

 

ThisThe date of this prospectus is dated August [    ], 2021.June 2, 2022.


TABLE OF CONTENTS

 

Page

EXPLANATORY NOTEPROSPECTUS SUMMARY

   i

ABOUT THIS PROSPECTUS

i

FORWARD-LOOKING STATEMENTS

1

OUR BUSINESS

12 

RISK FACTORS

   25

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

6 

USE OF PROCEEDS

   27 

THE EXCHANGEABLE SHARESSELLING STOCKHOLDERS

   28 

PLAN OF DISTRIBUTION

   2

INCOME TAX CONSIDERATIONS

39 

LEGAL MATTERS

   12 

EXPERTS

   1312 

WHERE YOU CAN FIND MOREADDITIONAL INFORMATION

   1312 

INCORPORATION OF CERTAIN INFORMATION WE INCORPORATE BY REFERENCE

   13 

INFORMATION NOT REQUIRED IN PROSPECTUS

15

EXPLANATORY NOTE

Meta Materials Inc. (fka Torchlight, Inc.), a Nevada corporation (the “Registrant”) hereby amends its Registration Statement on Form S-3 (File No. 333-256636) filed


ABOUT THIS PROSPECTUS

We urge you to carefully read this prospectus, together with the Securities and Exchange Commission (the “Commission”) on May 28, 2021information incorporated herein by filing this Pre-Effective Amendment No. 1 on Form S-3 relating to the shares of Registrant’s common stock issuable upon the exchange of shares of Exchangeco issued in connection to certain holders. On June 28, 2021, the Registrant completed the acquisition of Metamaterial Inc., an Ontario corporation (“Metamaterial”), in accordance with the terms of a statutory plan of arrangement (the “Arrangement”) under the Business Corporations Act (Ontario) on June  28, 2021.

ABOUT THIS PROSPECTUS

This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission (SEC) using a “shelf” registration process. As permittedreference as described under the rules of the SEC, this prospectus incorporates important information about Meta that is contained in documents that we file with the SEC, but that is not included in or delivered with this prospectus. You may obtain copies of these documents, without charge, from the website maintained by the SEC at www.sec.gov, as well as other sources. Seeheading “Where You Can Find More Information.Additional Information, before buying any of the securities being offered.

You should rely only on the information contained or incorporated by reference in this prospectusprospectus. We and in any prospectus supplement or in any free writing prospectus that we may provide you. Wethe selling stockholders have not authorized anyoneany other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus may only be used where it is legal to offer and sell shares of our common stock. If it is against the law in any jurisdiction to make an offer to sell these shares, or to solicit an offer from someone to buy these shares, then this prospectus does not apply to any person in that jurisdiction, and no offer or solicitation is made by this prospectus to any such person. You should not assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus, regardless of the time of delivery of this prospectus or of any sale of common stock. Our business, financial condition, results of operations and prospects may have changed since such date. Information contained on our website is not a part of this prospectus.

A prospectus supplement may add to, update or change the information contained in this prospectus. You should read both this prospectus and any applicable prospectus supplement together with additional information described below under the heading “Where You Can Find Additional Information.”

This prospectus contains references to trademarks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus, including logos, artwork and other visual displays, may appear without the ® or symbols, but such references are not intended to indicate, in any documentway, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies’ trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

PROSPECTUS SUMMARY

This summary highlights important features of this offering and the information contained elsewhere in or incorporated by reference into this prospectus. Because this is only a summary, it does not contain all of the information that you should consider before investing in our securities. You should carefully read this entire prospectus and any applicable prospectus supplement, including the information contained under the heading “Risk Factors,” and all other information included or any free writing prospectus is accurate as of any date, other than the date mentioned on the cover page of these documents. We are not making offers to sell the shares of common stock described inincorporated by reference into this prospectus and any applicable prospectus supplement in any jurisdictiontheir entirety before you invest in which an offer or solicitation is not authorized or in which the person making such offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make an offer or solicitation.our securities.

ReferencesUnless otherwise stated, all references in this prospectus to the terms “we,” “us,” “our,” “the Company” or “Meta” or otherthe “Company” and similar terms meandesignations refer to Meta Materials Inc. and, together with its consolidated subsidiaries, unless we state otherwisesubsidiaries.

Company Overview

The Company is a developer of high-performance functional materials and nanocomposites.

The Company has generated a portfolio of intellectual property and is now moving toward commercializing products at a performance and price point combination that has the potential to be disruptive in multiple market verticals. The Company’s platform technology includes holography, lithography, and medical wireless sensing. The underlying approach that powers the Company’s platform technologies comprises advanced materials, metamaterials and functional surfaces. These materials include structures that are patterned in ways that manipulate light, heat, and electromagnetic waves in unusual ways. The Company’s advanced structural design technologies and scalable manufacturing methods provide a path to broad commercial opportunities in aerospace and defense, automotive, energy, healthcare, consumer electronics, and data transmission.

Controlling light, heat, electricity, and radio waves have played key roles in technological advancements throughout history. Advances in electrical and electromagnetic technologies, wireless communications, lasers, and computers have all been made possible by challenging the understanding of how light and other types of energy naturally behave, and how it is possible to manipulate them.

Over the past 20 years, techniques for producing nanostructures have matured, resulting in a wide range of groundbreaking solutions that can control light, heat, and electromagnetic waves at very small scales. Some of the areas of advancement that have contributed to these techniques are photonic crystals, nanolithography, plasmonic phenomena and nanoparticle manipulation. From these advances, a new branch of material science has emerged – metamaterials. Metamaterials are composite structures, consisting of conventional materials such as metals and plastics, which are engineered by scientists to exhibit new or enhanced properties relating to reflection, refraction, diffraction, filtering, conductance and other properties that have the context indicates otherwise.potential for multiple commercial applications.

A metamaterial typically consists of a multitude of structured unit nano-cells that are comprised of multiple individual elements. These are referred to as meta-atoms. The individual elements are usually arranged in periodic patterns that, together, can manipulate light, heat, or electromagnetic waves. Development strategies for metamaterials and functional surfaces focus on structures that produce unusual and exotic electromagnetic properties by manipulating light and other forms of energy in ways that have never been naturally possible. They gain their properties not as much from their composition as from their exactingly designed structures. The precise shape, geometry, size, orientation, and arrangement of these nanostructures affect the light and other electromagnetic waves to create material properties that are not easily achievable with conventional materials.

iThe Company has many product concepts currently in various stages of development with multiple potential customers in diverse market verticals. The Company’s business model is to co-develop innovative products or applications with industry leaders that add value. This approach enables the Company to understand market dynamics and ensure the relevance and need for its products.


FORWARD-LOOKING STATEMENTSCompany Information

This prospectusOur principal executive offices are located at 1 Research Drive, Dartmouth, Nova Scotia B2Y 4M9 and our telephone number is (902) 482-5729. Our corporate website address is www.metamaterial.com. Our website and the information contained on, or that can be accessed through, the website will not be deemed to be incorporated by reference in, and is not considered part of, this prospectus may include predictions, estimates and otherfiling. You should not rely on any such information that are “forward-looking statements” within the meaningin making your decision whether to purchase our common stock. We make available free of the Private Securities Litigation Reform Act of 1995, Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Section 27A of the Securities Act . These forward-looking statements do not directly or exclusively relate to historical facts, including, without limitation, statements relating to the completion of the Arrangement. Without limiting the generality of the foregoing, words such as “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “would,” or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. Stockholders are cautioned that any forward-looking statements are not guarantees of future performance. These statements are based on the beliefs of the management of Meta, as the case may be, as well as the current expectations and assumptions, which such management believes to be reasonable, based on available information and involve a number of risks and uncertainties, all of which are difficult or impossible to predict accurately and many of which are beyondcharge through our control. As such,website our actual results may differ significantly from those expressed in any forward-looking statements.

These risks and uncertainties include, but are not limited to, factors and matters described or incorporated by reference in this prospectus and the following factors: (1) litigation relating to the Arrangement; (2) unexpected costs, charges or expenses resulting from the Arrangement; (3) the ability to realize anticipated benefits from the Arrangement; (4) competition from larger and more established companies in Meta’s markets; (5) Meta’s ability to successfully grow its business; and (6) legislative, regulatory and economic developments, including changing business conditions in the industries in which Meta operates and the economy in general as well as financial performance and expectations of Meta’s existing and prospective customers. Additional factors that may affect the future results of Meta are set forth in filings that Meta makes with the SEC from time to time, including its Annual Report on Form 10-K, forQuarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the year ended December 31, 2020,Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information contained in, or that can be accessed through, our website is not part of this prospectus.

Acquisition Agreement

On April 1, 2022, the Company completed the Acquisition in accordance with the terms of the Acquisition Agreement. Pursuant to the Acquisition Agreement, we agreed to file a registration statement with the Securities and Exchange Commission (the “SEC”) covering the resale of the Shares acquired by the selling stockholders pursuant to the Acquisition Agreement, and to use best efforts to cause such registration statement to become effective as soon as practicable.

The description of the Acquisition Agreement is not complete and is qualified in its entirety by reference to the Acquisition Agreement, which was filed with our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, as amended on June 30, 2021,1, 2022. See “Where You Can Find More Information” and its Current Report on Form 8-K, filed with“Information Incorporated by Reference.” The representations, warranties and covenants made by us in such agreement were made solely for the SEC on July 2, 2021, which are available on the SEC’s website at www.sec.gov, as well as factors discussed under the “Risk Factors” section of this prospectus.

In lightbenefit of the significant risksparties to such agreement, including, in some cases, for the purpose of allocating risk among the parties thereto, and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded asdeemed to be a representation, by uswarranty or any other person thatcovenant to you. Moreover, such results will be achieved, and readers are cautioned not to place undue reliance on such forward-looking information, which speak onlyrepresentations, warranties or covenants were made as of the date hereof. Except as required by law, we undertake no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For all of these reasons, Meta stockholdersan earlier date. Accordingly, such representations, warranties and covenants should not place undue reliancebe relied on forward-looking statements.

OUR BUSINESS

The descriptionas accurately representing the current state of our business underaffairs.

THE OFFERING

Common stock offered by selling stockholders

Up to 9,677,419 shares of common stock that were privately issued pursuant to the Acquisition Agreement, upon closing of the Acquisition.

Use of proceeds

We will not receive any proceeds from the sale of shares of common stock by the selling stockholders.

Offering Price

The selling stockholders may sell all or a portion of their shares through public or private transactions at prevailing market prices or at privately negotiated prices. See “Plan of Distribution.”

Risk factors

You should read the “Risk Factors” section included in this prospectus, and the risk factors incorporated by reference in this prospectus for a discussion of factors to consider carefully before deciding to invest in shares of our common stock.

Nasdaq Stock Market LLC symbol

“MMAT”

The selling stockholders named in this prospectus may offer and sell up to 9,677,419 shares of our common stock. Throughout this prospectus, when we refer to the heading “Business – Business Descriptionshares of Meta”our common stock being registered on behalf of the selling stockholders for offer and resale, we are referring to the shares of common stock issued to the selling stockholders in our Current Report on Formthe Acquisition, respectively, as described above. When we refer to the selling stockholders in this prospectus, we are referring to the selling stockholders identified in this prospectus and, as applicable, their permitted transferees or other 8-K,successors-in-interest filed with the SEC on July 2, 2021, whichthat may be amended, supplementedidentified in a supplement to this prospectus or, superseded from timeif required, a post-effective amendment to time by other reports we file with the SEC in the future,registration statement of which this prospectus is incorporated by reference into this prospectus.a part.

RISK FACTORS

Investing in our common stocksecurities involves a high degree of risk. PriorIn addition to making a decision about investing in our common stock,the risks and uncertainties discussed under “Special Note Regarding Forward-Looking Statements,” you should carefully consider the specific factors discussedrisks described below, and under the headingrisk factors set forth under “Risk Factors” in our most recent Annual Report on Form 10-K, as amended, which is incorporated by reference into this prospectus and which may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future, underand the heading “Risk Factors”risk factors and other information contained in our most recent Quarterly Report on Form 10-Q,any applicable prospectus supplement, before deciding whether to purchase any of the securities being registered pursuant to the registration statement of which is incorporated by reference into this prospectus is a part. If any of these risks actually occur, it may materially harm our business, financial condition, liquidity and which may be amended, supplementsresults of operations. As a result, the market price of our securities could decline, and you could lose all or superseded from time to time by other reports we file with the SEC in the future, and under the heading “Risk Factors” in our Current Report on Form 8-K, filed with the SEC on July 2, 2021, which is incorporated by reference into this prospectus and which may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future.part of your investment. The risks and uncertainties we have describeddescribe in the documents incorporated by reference herein are not the only risksones we face. Additional risks and uncertainties not presently known to us or that we currently deembelieve are immaterial may alsocould materially adversely affect our operations. Ifbusiness, operating results and financial condition, as well as adversely affect the value of an investment in our securities, and the occurrence of any of these risks actually occurs,might cause you to lose all or part of your investment.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus, any applicable prospectus supplement or free writing prospectus and our business,SEC filings that are incorporated by reference into this prospectus and any applicable prospectus supplement or free writing prospectus contain or incorporate by reference forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), or the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995, and such statements are subject to the “safe harbor” created by those sections. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. These statements are based on current plans, estimates and projections, and therefore, you are cautioned not to place undue reliance on them. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations andor financial condition, could suffer. In that case, the trading priceor otherwise, based on current beliefs of our common stockmanagement, as well as assumptions made by, and information currently available to management. No forward-looking statement can be guaranteed, and our actual results could decline,differ materially from those projected or discussed in our forward-looking statements for many reasons, including those risks. Given these uncertainties, readers should not place undue reliance on our forward-looking statements. These forward-looking statements speak only as of the date on which the statements were made and youare not guarantees of future performance. These factors and the other cautionary statements made in this prospectus should be read as being applicable to all related forward-looking statements whenever they appear in this prospectus. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could lose partdiffer materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Such factors may be amplified by global events such as the COVID-19 pandemic and the geopolitical tensions related to Russia’s actions in Ukraine and the potential impact on our business and the global economy. We disclaim any intention or allobligation to update or revise any forward-looking statement, whether as a result of your investment.new information, future events or otherwise.

Risks RelatedThese statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about competition from larger and more established companies in our markets, our ability to successfully grow its business and legislative, regulatory and economic developments, including changing business conditions in the Exchangeable Shares

Holders of exchangeable shares are expected to experience a delayindustries in receiving shareswhich we operate and the economy in general as well as financial performance and expectations of our common stockexisting and prospective customers. Additional factors that may affect our future results are set forth in filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the year ended December 31, 2021, as amended, which is available on the SEC’s website at www.sec.gov, as well as factors discussed under the “Risk Factors” section of this prospectus.

Forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions, and projections about the business and future financial results of the metamaterials industry, and other legal, regulatory and economic developments. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “intend,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “predict,” “potential,” “continue,” “likely,” and similar expressions (including their use in the negative) intended to identify forward-looking statements although not all forward-looking statements contain these identifying words. Actual results could differ materially from the date they request an exchange, which may affect the valueresults contemplated by these forward-looking statements due to a number of the shares the holder receives in an exchange.

Holders of exchangeable shares who requestfactors, including, but not limited to, receive shares of our common stock in exchange for their exchangeable shares will not receive shares of our common stock until several business days after the applicable request is received. During this period, the market price of our common stock may increase or decrease. Any such increase or decrease would affect the value of the consideration to be received by such holder of exchangeable shares upon a subsequent sale of the common stock receivedthose described in the exchange.documents we have filed with the SEC.

The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties that affect our business described in the “Risk Factors” section, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other documents filed by us from time to time with the SEC. See “Where You Can Find Additional Information” beginning on page 12 of this prospectus.

USE OF PROCEEDS

BecauseWe are filing the common stock will be issued upon exchange of the exchangeable shares, we will receive no cash proceeds from the offering.

THE EXCHANGEABLE SHARES

The rights of holders of exchangeable shares, including exchange rights, are described in the terms of the Plan of Arrangement, which is included as Schedule A to the Arrangement Agreement that is included as Exhibit 2.1 to this registration statement of which this prospectus forms a part.

PLAN OF DISTRIBUTION

The shares of common stock offered in this prospectus will be issued in exchange for exchangeable shares as described in the terms of the Plan of Arrangement, which is included as Schedule A to the Arrangement Agreement that is included as Exhibit 2.1 to this registration statement of which this prospectus forms a part. No broker, dealer or underwriter has been engaged in connection with this offering.

INCOME TAX CONSIDERATIONS

Material Canadian Federal Income Tax Considerations

The following summary describes the material Canadian federal income tax considerations in respect of an exchange or redemption of exchangeable shares, and the holding and disposition of shares of Meta common stock acquired upon the exchange or redemption of the exchangeable shares, generally applicable to a holder of exchangeable shares who, at all relevant times and for purposes of the Income Tax Act (Canada) and the regulations adopted thereunder (the “Tax Act”) and any applicable income tax treaty is, or is deemed to be, a resident of Canada at all relevant times (a “Resident Holder”) and who, for purposes of the Tax Act: (i) deals at arm’s length with Meta, Exchangeco, and Callco (as defined in the Plan of Arrangement); (ii) is not affiliated with Meta, Exchangeco, or Callco (as defined in the Plan of Arrangement); and (iii) holds exchangeable shares, and will hold the shares of Meta common stock acquired upon the exchange or redemption of such exchangeable shares, as capital property. Exchangeable shares and shares of Meta common stock will generally be considered to be capital property to a holder unless such exchangeable shares or shares of Meta common stock are held by the holder in the course of carrying on a business of buying and selling securities or were acquired in one or more transactions considered to be an adventure or concern in the nature of trade.

Certain Resident Holders whose exchangeable shares might not otherwise qualify as capital property may be entitled to make an irrevocable election in accordance with subsection 39(4) of the Tax Act to have their exchangeable shares, and every other “Canadian security” (as defined in the Tax Act) owned by such Resident Holder in the taxation year of the election and in all subsequent taxation years, deemed to be capital property. Where a Resident Holder has made an election with Exchangeco under section 85 of the Tax Act in respect of their shares exchanged for exchangeable shares, any exchangeable share received under the Arrangement will not be a Canadian security to such Resident Holder for this purpose. Resident Holders should consult their own tax advisors for advice as to whether the election is available or advisable in their own particular circumstances.

This summary does not apply to a Resident Holder: (i) with respect to whom Meta is or will be a “foreign affiliate” within the meaning of the Tax Act; (ii) that is a “specified financial institution” for the purposespart to permit holders of the Tax Act; (iii) that is a “financial institution” for the purposes of the mark-to-market rules in the Tax Act; (iv) an interest in which is a “tax shelter investment” for the purposes of the Tax Act; (v) that reports its “Canadian tax results” (as defined in the Tax Act) in a currency other than Canadian currency; or (vi) that has entered into or will enter into a “derivative forward agreement”, as defined in the Tax Act, in respect of exchangeable shares. Such holders should consult their own tax advisors.

This summary is based on the current provisions of the Tax Act and the regulations thereunder, and an understanding of the current administrative policies and assessing practices of the Canada Revenue Agency (the “CRA”) published in writing prior to the date hereof. This summary takes into account all specific proposals to amend the Tax Act and the regulations thereunder publicly announced in writing by or on behalf of the Minister of Finance (Canada) prior to the date hereof (the “Proposed Tax Amendments”) and assumes that all Proposed Tax Amendments will be enacted in the form proposed. However, no assurances can be given that the Proposed Tax Amendments will be enacted as proposed, or at all. This summary does not otherwise take into account or anticipate any changes in law whether by legislative, regulatory, administrative or judicial action or administrative policy or assessing practice nor does it take into account tax legislation or considerations of any province, territory or foreign jurisdiction, which may differ from those discussed herein.

This summary is of a general nature only and is not, and is not intended to be, and should not be construed to be, legal, business, or tax advice to any particular holder. This summary is not exhaustive of all Canadian federal income tax considerations. Consequently, holders are urged to consult their own tax advisors to determine the particular tax effects to them under Canadian federal, provincial, territorial or local tax laws and under foreign tax laws, having regard to their own particular circumstances.

For purposes of the Tax Act, all amounts relating to the acquisition, holding or disposition of securities (including dividends, adjusted cost base and proceeds of disposition) must be expressed in Canadian dollars.

Amounts denominated in U.S. dollars must be converted into Canadian dollars, generally based on the Bank of Canada exchange rate on the date such amounts arise.

Redemption, Exchange and Disposition of Exchangeable Shares

A Resident Holder will be considered to have disposed of exchangeable shares:

(i)

on a redemption (including pursuant to a retraction request) of such exchangeable shares by Exchangeco; and

(ii)

on an acquisition of such exchangeable shares by Meta or Callco pursuant to a call right (acquired by Meta and Callco under Arrangement).

However, as discussed below, the Canadian federal income tax consequences of the disposition for the Resident Holder will be different depending on whether the event giving rise to the disposition is a redemption or retraction by Exchangeco or an acquisition by Meta or Callco.

A Resident Holder who exercises the right to require the redemption of an exchangeable share by giving a retraction request cannot control whether the exchangeable share will be acquired by Meta or Callco under a call right (acquired by Meta or Callco under the Arrangement) or redeemed by Exchangeco.

Redemption or Retraction of Exchangeable Shares

On a redemption (including a retraction) of an exchangeable share by Exchangeco, the Resident Holder of that exchangeable share will be deemed to have received a dividend equal to the amount, if any, by which the “redemption proceeds” exceed the paid-up capital (for purposes of the Tax Act) of the exchangeable share at the time of redemption. See “Dividends on Exchangeable Shares” below. On the redemption, the Resident Holder of an exchangeable share will also be considered to have disposed of the exchangeable share for proceeds of disposition equal to the “redemption proceeds” less the amount of such deemed dividend. The Resident Holder will, in general, realize a capital gain (or a capital loss) equal to the amount by which such proceeds of disposition, net of any reasonable costs of disposition, exceed (or are less than) the adjusted cost base to the Resident Holder of the exchangeable shares. For this purpose, the “redemption proceeds” of an exchangeable share will be equal to the sum of (i) the fair market value at the time of the redemption of the shares of Meta common stock received by the Resident Holder, (ii) the amount, if any, of all declared, payable and unpaid cash dividends on the exchangeable share received by the Resident Holder, (iii) the amount, if any, of all dividends declared and payable or paid in respect of each share of Meta common stock which have not, at such time, been declared or paid on the exchangeable share and are received by the holder on the redemption, and (iv) the fair market value at the time of the redemption of any stock or other property constituting any declared, payable and unpaid non-cash dividends on the exchangeable share received by the Resident Holder. For a description of the tax treatment of capital gains and capital losses, see “Taxation of Capital Gains and Capital Losses” below.

Dividends on Exchangeable Shares

In the case of a Resident Holder who is an individual (other than certain trusts), dividends received or deemed to be received on the exchangeable shares will be included in computing the Resident Holder’s income and will be subject to the gross-up and dividend tax credit rules that apply to taxable dividends received from taxable Canadian corporations. Provided that appropriate designations are made by Exchangeco at the time the dividend or deemed dividend is paid, such dividend will be treated as an “eligible dividend” for the purposes of the Tax Act and a Resident Holder who is an individual resident in Canada will be entitled to an enhanced dividend tax credit in respect of such dividend. There are limitations on the ability of a corporation to designate dividends and deemed dividends as eligible dividends.

In the case of a Resident Holder that is a corporation, dividends received or deemed to be received on the exchangeable shares will be required to be included in computing the corporation’s income for the taxation year in which such dividends are received, and such dividends will generally be deductible in computing the corporation’s taxable income. In certain circumstances, subsection 55(2) of the Tax Act will treat a taxable dividend received by a Resident Holder that is a corporation as proceeds of disposition or a capital gain. Resident Holders that are corporations should consult their own tax advisors having regard to their own circumstances.

A Resident Holder that is a “private corporation” (as defined in the Tax Act) or any other corporation resident in Canada and controlled or deemed to be controlled by or for the benefit of an individual or a related group of individuals may be liable under Part IV of the Tax Act to pay a refundable tax of 38 1/3% on dividends received or deemed to be received on the exchangeable shares to the extent that such dividends are deductible in computing the Resident Holder’s taxable income.

A Resident Holder that, throughout the relevant taxation year, is a “Canadian-controlled private corporation” (as defined in the Tax Act) may be liable to pay a refundable tax of 10 2/3% on its “aggregate investment income” (as defined in the Tax Act), including any dividends that are not deductible in computing taxable income.

The exchangeable shares will be taxable preferred shares and short-term preferred shares for the purpose of the Tax Act. However, a Resident Holder of exchangeable shares who receives or is deemed to receive dividends on such shares will not be subject to the 10% tax under Part IV.1 of the Tax Act.

Meta intends to take the position that the exchangeable shares are properly characterized as stock of Meta for U.S. federal income tax purposes. If the exchangeable shares are treated as stock of Meta for U.S. federal income tax purposes, any dividends paid by Exchangeco with respect to the exchangeable shares would generally be subject to U.S. non-resident withholding tax. Exchangeco currently intends to withhold U.S. non-resident withholding tax from such dividends paid to a Resident Holder. Any U.S. non-resident withholding tax on such dividends may be eligible to be credited against the Resident Holder’s income tax (where such Resident Holder is entitled to benefits under the Canada – United States Tax Convention (1980)) or deducted from income subject to certain limitations under the Tax Act. Such Resident Holders are urged to consult their own tax advisors having regard to their own particular circumstances.

Exchange of Exchangeable Shares with Meta or Callco

On the exchange of an exchangeable share by the Resident Holder with Meta or Callco for shares of the Meta common stock, the Resident Holder will generally realize a capital gain (or a capital loss) to the extent the proceeds of disposition of the exchangeable share, net of any reasonable costs of disposition, exceed (or are less than) the adjusted cost base to the Resident Holder of the exchangeable share. For these purposes, the proceeds of disposition will be the fair market value of the shares of Meta common stock received upon exchange plus an amount equal to declared and unpaid dividends on the exchangeable share. For a description of the tax treatment of capital gains and capital losses, see “Taxation of Capital Gains and Capital Losses” below. The acquisition by Meta or Callco of an exchangeable share from the Resident Holder thereof will not generally result in a deemed dividend to the Resident Holder.

Disposition of Exchangeable Shares other than on Redemption, Retraction or Exchange

A disposition or deemed disposition of exchangeable shares by a Resident Holder, other than on the redemption, retraction or exchange of the shares, will generally result in a capital gain (or a capital loss) to the extent that the proceeds of disposition, net of any reasonable costs of disposition, exceed (or are less than) the adjusted cost base to the Resident Holder of those exchangeable shares immediately before the disposition. For a description of the tax treatment of capital gains and capital losses, see “Taxation of Capital Gains and Capital Losses” below.

Dividends on Shares of Meta Common Stock

In the case of a Resident Holder who is an individual, dividends received or deemed to be received by the individual on the shares of Meta common stock will be required to be included in computing the individual’s income for the taxation year in which such dividends are received and will not be subject to the gross-up and dividend tax credit rules in the Tax Act.

In the case of a Resident Holder that is a corporation, dividends received or deemed to be received by the corporation on the shares of Meta common stock will be required to be included in computing the corporation’s income for the taxation year in which such dividends are received and generally will not be deductible in computing the corporation’s taxable income.

Any U.S. non-resident withholding tax on such dividends generally should be eligible, subject to certain limitations under the Tax Act, to be credited against the Resident Holder’s income tax or deducted from income.

Acquisition and Disposition of Shares of Meta Common Stock

The cost of shares of Meta common stock received on the retraction, redemption or exchange of an exchangeable share will be equal to the fair market value of such shares of Meta common stock at the time of such event and will generally be averaged with the adjusted cost base of any other shares of Meta common stock held at that time by the Resident Holder as capital property for the purpose of determining the Resident Holder’s adjusted cost base of such shares of Meta common stock.

Generally, on a disposition or deemed disposition of shares of Meta common stock, a Resident Holder will realize a capital gain (or a capital loss) equal to the amount, if any, by which the proceeds of disposition exceed (or are less than) the aggregate of the adjusted cost base to the Resident Holder of the shares of Meta common stock immediately before the disposition or deemed disposition and any reasonable costs of disposition. For a description of the tax treatment of capital gains and capital losses, see “Taxation of Capital Gains and Capital Losses” below.

Taxation of Capital Gains and Capital Losses

Generally, one-half of any capital gain (a “taxable capital gain”) realized by a Resident Holder in a taxation year must be included in the Resident Holder’s income for the year, and one-half of any capital loss (an “allowable capital loss”) realized by a Resident Holder in a taxation year must be deducted from taxable capital gains realized by the holder in that year (subject to and in accordance with rules contained in the Tax Act). Allowable capital losses for a taxation year in excess of taxable capital gains realized in a taxation year generally may be carried back and deducted in any of the three preceding taxation years or carried forward and deducted in any subsequent taxation year against net taxable capital gains realized in such years, to the extent and under the circumstances described in the Tax Act.

A Resident Holder that throughout the relevant taxation year, is a “Canadian-controlled private corporation” (as defined in the Tax Act) may be liable to pay a refundable tax on its “aggregate investment income” (as defined in the Tax Act), including amounts in respect of net taxable capital gains.

The amount of any capital loss realized by a Resident Holder that is a corporation on the disposition of a share may be reduced by the amount of certain dividends previously received (or deemed to be received) by the Resident Holder on such share (or another share where the share has been acquired in exchange for such other share) to the extent and under circumstances prescribed by the Tax Act. Similar rules may apply where a share is owned by a partnership or trust of which a corporation, trust or partnership is a member or beneficiary. Holders to whom these rules may be relevant should consult their own tax advisors.

Foreign Property Information Reporting

In general, a “specified Canadian entity” for a taxation year or fiscal period whose total cost amount of “specified foreign property” (both as defined in the Tax Act) at any time in the year or fiscal period exceeds $100,000, is required to file an information return for the year or period disclosing prescribed information, including the cost amount, any dividends received in the year, and any gains or losses realized in the year in respect of such property.

Exchangeable shares and shares of Meta Common Stock will constitute specified foreign property to a holder. Accordingly, holders of exchangeable shares and shares of Meta common stock should consult their own tax advisors regarding compliance with these rules.

Offshore Investment Fund Property

The Tax Act contains rules which may require a taxpayer to include in income in each taxation year an amount in respect of the holding of an “offshore investment fund property”. These rules could apply to a Resident Holder in respect of a share of Meta common stock or an exchangeable share if two conditions are both satisfied.

The first condition for such rules to apply is that the value of the share of Meta common stock may reasonably be considered to be derived, directly or indirectly, primarily from portfolio investments in: (i) shares of one or more corporations, (ii) indebtedness or annuities, (iii) interests in one or more corporations, trusts, partnerships, organizations, funds or entities, (iv) commodities, (v) real estate, (vi) Canadian or foreign resource properties, (vii) currency of a country other than Canada, (viii) rights or options to acquire or dispose of any of the foregoing, or (ix) any combination of the foregoing (“Investment Assets”).

The second condition for such rules to apply to a Resident Holder is that it must be reasonable to conclude that one of the main reasons for the Resident Holder acquiring or holding a share of Meta common stock or an exchangeable share was to derive a benefit from portfolio investments in Investment Assets in such a manner that the taxes, if any, on the income, profits and gains from such Investment Assets for any particular year are significantly less than the tax that would have been applicable under Part I of the Tax Act had the income, profits and gains been earned directly by the Resident Holder.

If applicable, these rules would generally require a Resident Holder to include in income for each taxation year in which the Resident Holder owns a share of Meta common stock or an exchangeable share (i) an imputed return for the taxation year computed on a monthly basis and determined by multiplying the Resident Holder’s “designated cost” (as defined in the Tax Act) of such share at the end of the month by 1/12th of the aggregate of the applicable prescribed rate of interest for the period that includes such month and two percent, less the amount of (ii) the Resident Holder’s income for the year (other than a capital gain) from such share determined without reference to these rules. Any amount required to be included in computing a Resident Holder’s income under these provisions will be added to the adjusted cost base to the Resident Holder of its share of Meta common stock or its exchangeable share, as the case may be.

The application of these rules depends, in part, on the reasons for a Resident Holder acquiring or holding shares of Meta common stock or exchangeable shares. Resident Holders are urged to consult their own tax advisors regarding the application and consequences of these rules, in their own particular circumstances.

Eligibility for Investment

Provided that the shares of Meta common stock are listed on a “designated stock exchange” within the meaning of the Tax Act (which includes the NASDAQ) at a particular time, the shares of Meta common stock will be qualified investments under the Tax Act for trusts governed by a registered retirement savings plan

(“RRSP”), a registered retirement income fund (“RRIF”), a registered education savings plan, a deferred profit sharing plan, a registered disability savings plan and a tax-free savings account (“TFSA”), all as defined in the Tax Act.

Notwithstanding that the shares of the Meta common stock may be qualified investments for trusts governed by a TFSA, an RRSP or a RRIF, the holder of a TFSA or the annuitant of an RRSP or RRIF, as the case may be, may be subject to a penalty tax under the Tax Act if such shares are a “prohibited investment” within the meaning of the Tax Act for the particular TFSA, RRSP or RRIF. The shares of Meta common stock will generally not be a prohibited investment for a TFSA, an RRSP or RRIF provided that the holder of the TFSA, or the annuitant of the RRSP or RRIF, as applicable, deals at arm’s length with Meta within the meaning of the Tax Act and does not have a “significant interest” within the meaning of the Tax Act in Meta. Resident Holders should consult their own tax advisors to ensure that the shares of Meta common stock will not be a prohibited investment for a trust governed by a TFSA, RRSP or RRIF in their particular circumstances.

Material U.S. Federal Income Tax Consequences

The following is a summary of certain material U.S. federal income tax considerations generally applicable to Non-U.S. Holders (as defined below) who receive solely shares of Meta common stock in exchange for exchangeable shares (the “Exchange” for purposes of this summary).

The following summary is based on the U.S. Internal Revenue Code of 1986, as amended (the “Code”), U.S. Treasury Regulations thereunder, published rulings of the U.S. Internal Revenue Service (“IRS”) and judicial and administrative interpretations thereof, in each case as in effect and available on the date of this prospectus. Any of the authorities on which this summary is based could be changed in a material and adverse manner at any time, and any such change could be applied on a retroactive basis. Except as explicitly set forth herein, this summary does not discuss the potential effects, whether adverse or beneficial, of any proposed legislation or regulations. No legal opinion from U.S. legal counsel or ruling from the IRS has been requested, or will be obtained, regarding the U.S. federal income tax consequences of the Plan of Arrangement, including the exchange of exchangeable shares for Meta common stock. This summary is not binding on the IRS, and the IRS is not precluded from taking a position that is different from, and contrary to, the positions taken in this summary. In addition, because the authorities on which this summary is based are subject to various interpretations, the IRS and the U.S. courts could disagree with one or more of the positions taken in this summary.

This summary is for general information purposes only and does not purport to be a complete analysis or listing of all potential U.S. federal income tax consequences that may apply to a Non-U.S. Holders as a result of the Exchange. In addition, this summary does not address U.S. Holders (as defined below) and does not take into account the individual facts and circumstances of any particular Non-U.S. Holder that may affect the U.S. federal income tax consequences applicable to such Non-U.S. Holder, nor does this summary address the U.S. federal income tax considerations of the Exchange to holders that are subject to special provisions under the Code, including the following holders: (a) holders that are tax-exempt organizations, qualified retirement plans, individual retirement accounts, or other tax-deferred accounts; (b) holders that are financial institutions, insurance companies, real estate investment trusts, or regulated investment companies; (c) holders that are dealers in securities or currencies or holders that are traders in securities that elect to apply a mark-to-market accounting method; (d) holders subject to the alternative minimum tax provisions of the Code; (e) holders that own exchangeable shares as part of a straddle, hedging transaction, conversion transaction, constructive sale, or other arrangement involving more than one position; (f) holders that hold exchangeable shares other than as a capital asset within the meaning of Section 1221 of the Code; (g) holders that own or have owned directly, indirectly or constructively, 10% or more of Exchangeco’s voting securities; (h) holders that are controlled foreign corporations, passive foreign investment companies and corporations that accumulate earnings to avoid U.S. federal income tax; (i) holders that are U.S. expatriates or former long-term residents of the United States; (j) holders that hold, have held, or will hold, directly, indirectly or constructively, more than 5% of the shares of

Meta common stock; (k) certain former citizens or long-term residents of the United States; and (l) holders that are classified for U.S. federal income tax purposes as partnerships and other pass-through entities and investors therein. Exchangeable share holders that are subject to special provisions under the Code, including holders described above, should consult their own tax advisor regarding the U.S. federal, U.S. state and local, and foreign tax consequences relating to the Exchange.

If an entity or arrangement classified as a partnership for U.S. federal income tax purposes owns exchangeable shares, the U.S. federal income tax consequences of the Exchange to such partnership and the partners of such partnership generally will depend upon the activities of the partnership and status of such partners. Holders that are classified as partnerships for U.S. federal income tax purposes, and the partners of such entities, should consult their own tax advisors regarding the U.S. federal income tax consequences of the Exchange.

This summary does not address any U.S. estate, state, local or foreign tax consequences relating to the Exchange or any consequences under the alternative minimum tax provisions of the Code or the tax on net investment income imposed by Section 1411 of the Code. Each Non-U.S. Holder should consult its own tax advisor regarding the U.S. estate, state, local and foreign tax consequences arising from and relating to the Exchange.

For purposes of this summary, a “U.S. Holder” means for U.S. federal income tax purposes, (a) an individual who is a citizen or resident of the U.S., (b) a corporation, or other entity classified as a corporation for U.S. federal income tax purposes, that is created or organized in or under the laws of the U.S., any state in the U.S. or the District of Columbia, (c) an estate if the income of such estate is subject to U.S. federal income tax regardless of the source of such income, or (d) a trust if (i) such trust has validly elected to be treated as a U.S. person for U.S. federal income tax purposes or (ii) a U.S. court is able to exercise primary supervision over the administration of such trust and one or more U.S. persons have the authority to control all substantial decisions of such trust. This summary does not address the tax consequences of the Exchange to any U.S. Holder.

For purposes of this summary, a “Non-U.S. Holder” is a beneficial owner (for U.S. federal income tax purposes) of exchangeable shares other than a U.S. Holder. The U.S. federal income tax consequences to Non-U.S. Holders depend in significant part on the provisions of the specific treaty, if any, in place from time to time between the United States and the Non-U.S. Holder’s jurisdiction. Non-U.S. Holders are urged to consult a tax advisor who has knowledge of the particular treaty provisions applicable to the Non-U.S. Holder in order to accurately determine the specific tax treatment applicable to them. The following is therefore a very general discussion of such treatment without specific reference to any particular treaty.

U.S. Federal Income Tax Characterization of the Exchangeable Shares

There is no direct authority addressing the characterization and treatment for U.S. federal income tax purposes of instruments with the terms of the exchangeable shares under the facts of the Scheme of Arrangement. Because the exchangeable shares are exchangeable into Meta common stock, have dividend rights based on the dividends paid with respect to Meta common stock, and have the benefit of voting rights similar to the voting rights attributable to Meta common stock, Meta and Exchangeco intend to take the position that the exchangeable shares constitute voting common stock of Meta for U.S. federal income tax purposes.

However, this characterization is not binding on the IRS, and the IRS or the courts could treat the exchangeable shares as stock of Exchangeco for U.S. federal income tax purposes. Neither Meta nor Exchangeco has requested, nor do they intend to request, an opinion from United States legal counsel or a ruling from the IRS regarding the U.S. federal income tax classification of the exchangeable shares.

Tax Consequences to Non-U.S. Holders Arising from the Exchange

Consequences if the Exchangeable Shares Are Treated as Stock of Meta

If the exchangeable shares are treated as stock of Meta for U.S. federal income tax purposes, as discussed above in the discussion titled “U.S. Federal Income Tax Characterization of the Exchangeable Shares,” Non-U.S. Holders will generally not be subject to U.S. federal income tax on the gain (if any) realized in the Exchange.

However, if Meta is or has been a “U.S. real property holding corporation,” or “USRPHC,” for U.S. federal income tax purposes during the shorter of the five-year period preceding the Exchange, or the Non-U.S. Holder’s holding period for the exchangeable shares, a Non-U.S. Holder in the Exchange nonetheless would generally be subject to U.S. federal income tax as described below in “Dispositions of Shares of Meta Common Stock” as a result of Meta constituting a USRPHC, unless the common stock of Meta is regularly traded on an established securities market, under applicable Treasury Regulations, and: (i) the exchangeable shares are regularly traded on an established securities market and such Non-U.S. Holder has never beneficially owned, directly, indirectly, or constructively, more than 5% of the exchangeable shares, (ii) the exchangeable shares are not regularly traded on an established securities market and on the date such Non-U.S. Holder acquired the exchangeable shares such exchangeable shares had a fair market value no greater than 5% of the fair market value of the then outstanding shares of Meta common stock, or (iii) such non-U.S. Holder files a United States federal income tax return that contains a statement meeting the requirements of Temporary Treasury Regulations Section 1.897-5T(d)(1)(iii), in each case determined under applicable Treasury Regulations.

Meta does not believe it is a USRPHC or that it will become one in the future. The provisions of the Code and Treasury Regulations regarding these determinations are complex and subject to differing interpretations. Non-U.S. Holders should consult their tax advisors regarding the application of these rules.

Consequences if the Exchangeable Shares Are Not Treated as Stock of Meta

If the exchangeable shares are not treated as stock of Meta for U.S. federal income tax purposes, as discussed above in the discussion titled “U.S. Federal Income Tax Characterization of the Exchangeable Shares,” the tax consequences of the Exchange to a Non-U.S. Holder generally will be subject to the rules discussed below in the discussion titled “Dispositions of Shares of Meta Common Stock.” In general, a Non-U.S. Holder will not be subject to U.S. federal income tax on the gain (if any) realized in the Exchange unless (i) the gain is effectively connected with the conduct by the Non-U.S. Holder of a trade or business, or, if required by an applicable treaty, attributable to a permanent establishment maintained by the Non-U.S. Holder, in the United States or (ii) the Non-U.S. Holder is an individual who is present in the United States for 183 days or more in the taxable year of disposition and certain other conditions are met, unless an applicable income tax treaty provides otherwise. Non-U.S. Holders described in (i) and (ii) above should consult the corresponding descriptions contained in the discussion entitled “Dispositions of Shares of Meta Common Stock” for a description of the applicable tax consequences of the Exchange.

In addition, if Meta is or has been a USRPHC, the description under “Consequences if the Exchangeable Shares Are Treated as Stock of Meta” relating to the consequences of USRPHC status would generally apply, except that (iii) in such discussion would not apply.

Tax Consequences to Non-U.S. Holders Arising from the Ownership or Disposition of Shares of Meta Common Stock

Receipt of Distributions on Shares of Meta Common Stock

Distributions, if any, received with respect to the shares of Meta common stock out of Meta’s current or accumulated earnings and profits, as determined for U.S. federal income tax purposes, will be subject to U.S.

withholding tax at a rate of 30% (or lower applicable treaty rate) unless the Non-U.S. Holder establishes that such dividends are effectively connected with such holder’s U.S. trade or business. A Non-U.S. Holder may be able to claim benefits (if any) under an applicable treaty with respect to such withholding taxes. However, there can be no assurance that treaty benefits will be available and Non-U.S. Holders should consult their tax advisors as to the applicability of treaty benefits in such circumstances. In addition, a Non-U.S. Holder will be taxed in the same manner as a U.S. Holder on dividends received that are effectively connected with the Non-U.S. Holder’s conduct of a trade or business or, if required by an applicable treaty attributable to a permanent establishment by the Non-U.S. Holder, in the United States. A Non-U.S. Holder that is classified as a corporation for U.S. federal income tax purposes may also be subject to an additional branch profits tax at a 30% rate (or lower applicable treaty rate) on dividend income that is effectively connected with a U.S. trade or business. To the extent a distribution exceeds Meta’s current or accumulated earnings and profits, it will first constitute a tax-free return of capital that is applied against and reduces, but not below zero, the adjusted tax basis of a Non-U.S. Holder’s shares of Meta common stock. Any remainder will constitute capital gain from the disposition of Meta common stock, the treatment of which is described below.

Dispositions of Shares of Meta Common Stock

Except as otherwise described below in the discussions of backup withholding and FATCA, a Non-U.S. Holder generally will not be subject to U.S. federal income tax on any gain realized upon the sale or other disposition of Meta common stock unless:

the gain is effectively connected with the Non-U.S. Holder’s conduct of a U.S. trade or business (and, if required by an applicable income tax treaty, the gain is attributable to a permanent establishment maintained by the Non-U.S. Holder in the United States);

the Non-U.S. Holder is a non-resident alien individual who is present in the United States for a period or periods aggregating 183 days or more during the calendar year in which the sale or disposition occurs, and other conditions are met; or

the Meta common stock constitutes a United States real property interest by reason of Meta’s status as a USRPHC for U.S. federal income tax purposes at any time within the shorter of the five-year period preceding the Non-U.S. Holder’s disposition of, or the Non-U.S. Holder’s holding period for, the Meta common stock, and, in the case where shares of our common stock are regularly traded on an established securities market, the Non-U.S. Holder owns, or are treated as owning, more than 5% of our common stock at any time during the foregoing period.

Generally, a corporation is a “United States real property holding corporation” if the fair market value of its United States real property interests equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests and its other assets used or held for use in a trade or business (all as determined for United States federal income tax purposes). Meta does not believe that it is a USRPHC, or that it will become a USRPHC in the future, and this discussion assumes this is the case. However, because the determination of whether Meta is a USRPHC depends on the fair market value of Meta’s U.S. real property relative to the fair market value of Meta’s other business assets, there can be no assurance that Meta will not become a USRPHC in the future. Even if Meta becomes a USRPHC, however, as long as Meta’s common stock is regularly traded on an established securities market, such common stock will be treated as U.S. real property interests only if a Non-U.S. Holder actually or constructively hold more than 5% of such regularly traded common stock at any time during the shorter of the five-year period preceding the Non-U.S. Holder’s disposition of, or the Non-U.S. Holder’s holding period for, the Meta common stock. No assurance can be provided that Meta’s common stock will be regularly traded on an established securities market at all times for purposes of the rules described above.

A Non-U.S. Holder described in the first bullet above will generally be requiredsection entitled “Selling Stockholders” to pay tax on the net gain derived from the sale under regular graduated U.S. federal income tax rates (and a corporate Non-U.S. Holder described in the first bullet above also may be subject to the branch profits tax at a 30% rate), unless otherwise

provided by an applicable income tax treaty. A Non-U.S. Holder described in the second bullet above will generally be required to pay a flat 30% tax (or such lower rate specified by an applicable income tax treaty) on the gain derived from the sale, which gain may be offset by U.S. source capital losses for the year (provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to such losses). Non-U.S. Holders should consult your tax advisor with respect to whether any applicable income tax or other treaties may provide for different rules.

Backup Withholding and Information Reporting

Information returns may be filed with the IRS in connection with payments on the shares of Meta common stock or exchangeable shares and the proceeds from a sale or other disposition ofresell such shares. Holders of shares of Meta common stock or exchangeable shares may be subject to U.S. backup withholding tax on these payments if they fail to provide their taxpayer identification numbers to the paying agentWe are not selling any securities under this prospectus and comply with certification procedures or otherwise establish an exemption from backup withholding. The amount ofwe will not receive any backup withholding from a payment will be allowed as a credit against the holder’s U.S. federal income tax liability and may entitle the holder to a refund, provided that the required information is timely furnished to the IRS.

Foreign Account Tax Compliance Act Withholding

The Foreign Account Tax Compliance Act and the rules and regulations promulgated thereunder, collectively, FATCA, generally imposes withholding tax at a rate of 30% on dividends on and gross proceeds from the sale or other disposition of Metashares of our common stock paidheld by the selling stockholders. The selling stockholders will receive all of the proceeds from this offering.

The selling stockholders will pay any discounts, commissions, fees of underwriters, selling brokers or dealer managers and expenses incurred by the selling stockholders for brokerage, accounting, tax or legal services or any other expenses incurred by the selling stockholders in disposing of the shares. We will bear all other costs, fees and expenses incurred in effecting the registration of the shares covered by this prospectus, including, without limitation, all registration and filing fees, printing fees, Nasdaq listing fees and fees and expenses of our counsel and our accountants.

SELLING STOCKHOLDERS

This prospectus covers the resale or other disposition of up to “foreign financial institutions” (as specially defined9,677,419 shares of our common stock by the selling stockholders named below, and their donees, pledgees, transferees or other successor-in-interest selling shares of common stock or interests in shares of common stock received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership distribution or other transfer (collectively, the “selling stockholders”). These shares consist of 9,677,419 shares of common stock that were privately issued pursuant to the Acquisition Agreement, upon closing of the Acquisition. See “Prospectus Summary—Acquisition Agreement.”

The table below sets forth, to our knowledge, information concerning the beneficial ownership of shares of our common stock by the selling stockholders as of May 27, 2022. The information in the table below with respect to the selling stockholders has been obtained from the respective selling stockholders. The selling stockholders may sell all, some or none of the shares of common stock subject to this prospectus. See “Plan of Distribution” as may be supplemented and amended from time to time. We do not know how long the selling stockholders will hold the shares before selling them, and except as set forth below under these rules), unless such institution enters into an agreement“Relationship with Selling Stockholders,” we currently have no agreements, arrangements or understandings with the U.S. government to withhold on certain payments and to collect and provide to the U.S. tax authorities substantial informationselling stockholders regarding the U.S. account holders of such institution (which includes certain equity and debt holders of such institution, as well as certain account holders that are foreign entities with U.S. owners) or otherwise establishes an exemption. FATCA also generally imposes a U.S. federal withholding tax of 30% on dividends on and gross proceeds from the sale or other disposition of Metaany of the shares.

The number of shares of common stock paidbeneficially owned prior to a “non-financial foreign entities” (as specially definedthe offering for each selling stockholder includes (i) all shares of our common stock beneficially held by such selling stockholder as of May 27, 2022, (ii) the number of shares of our common stock that may be offered under these rules) unless such entity providesthis prospectus, and (iii) the withholding agent with a certification identifying certain substantial directnumber and indirect U.S. ownerspercentage of our common stock beneficially owned by the selling stockholders assuming all of the entityshares of our common stock registered hereunder are sold. The table below and provides certain informationfootnotes assume that the selling stockholders will sell all of the shares listed. However, because the selling stockholders may sell all or some of their shares under this prospectus from time to time, or in another permitted manner, we cannot assure you as to the actual number of shares that will be sold by the selling stockholders or that will be held by the selling stockholders after completion of any sales. We do not know how long the selling stockholders will hold the shares before selling them. The percentages of shares owned after the offering are based on 296,692,943 shares of common stock outstanding as of May 27, 2022, which includes the outstanding shares of common stock offered by this prospectus.

Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to such U.S. owners, certifiesour common stock. Generally, a person “beneficially owns” shares of our common stock if the person has or shares with others the right to vote those shares or to dispose of them, or if the person has the right to acquire voting or disposition rights within 60 days. The inclusion of any shares in this table does not constitute an admission of beneficial ownership for any selling stockholder named below.

Information about the selling stockholders may change over time. Any changed information will be set forth in an amendment to the registration statement or supplement to this prospectus, to the extent required by law.

   Shares of
Common
Stock
Beneficially
Owned Prior
to
Offering
   Number of
Shares of
Common
Stock
Being
Offered (1)
   Shares of Common
Stock to be
Beneficially Owned
After Offering (2)
 
Name of Selling Stockholder  Number   Offered   Number   Percentage 

Dmitry Yarmolich

   4,838,710    4,838,710    —      —   

Dzianis Yarmolich

   4,838,709    4,838,709    —      —   

(1)

The number of shares of our common stock in the column “Number of Shares of Common Stock Being Offered” represents all of the shares of our common stock that a selling stockholder may offer and sell from time to time under this prospectus.

(2)

We do not know when or in what amounts a selling stockholder may offer shares for sale. The selling stockholders might not sell any or might sell all of the shares offered by this prospectus. Because the selling stockholders may offer all or some of the shares pursuant to this offering, and because, except as set forth elsewhere in this prospectus, there are currently no agreements, arrangements or understandings with respect to the sale of any of the shares, we cannot estimate the number of the shares that will be held by the selling stockholders after completion of the offering. However, for purposes of this table, we have assumed that, after completion of the offering, none of the shares covered by this prospectus will be held by the selling stockholders.

Relationship with Selling Stockholders

As discussed in greater detail above under the section “Prospectus Summary—Acquisition Transaction,” on March 31, 2022, we entered into the Acquisition Agreement pursuant to which we issued shares of common stock to the selling stockholders in exchange for all of the outstanding shares of Plasma App Ltd., and agreed with the selling stockholders to file a registration statement to enable the resale of the shares of common stock covered by this prospectus. Upon the completion of the Acquisition, each selling stockholder became a service provider to the Company.

Plan of Distribution

The selling stockholders, which as used herein includes donees, pledgees, transferees or other successors-in-interest selling shares of common stock or interests in shares of common stock received after the date of this prospectus from a selling stockholder as a gift, pledge or other transfer, may, from time to time, sell, transfer or otherwise establishesdispose of any or all of their shares of common stock or interests in shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.

The selling stockholders may use any one or more of the following methods when disposing of shares or interests therein:

ordinary brokerage transactions and certifiestransactions in which the broker-dealer solicits purchasers;

block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction;

purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

an exemption. exchange distribution in accordance with the rules of the applicable exchange;

privately negotiated transactions;

short sales effected after the date the registration statement of which this prospectus is a part is declared effective by the SEC;

through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;

broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share;

a combination of any such methods of sale; and

any other method permitted by applicable law.

The withholding provisionsselling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees

or secured parties may offer and sell the shares of common stock, from time to time, under FATCA generally applythis prospectus, or under an amendment to dividendsthis prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933, as amended (the “Securities Act”), amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling stockholders for purposes of this prospectus.

In connection with the sale of our common stock or interests therein, the selling stockholders may, subject to compliance with our insider trading policy, enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

The aggregate proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common stock less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. The Company will not receive any of the proceeds from this offering.

The selling stockholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided that they meet the criteria and conform to the requirements of that rule, or another available exemption from the registration requirements of the Securities Act.

The selling stockholders and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may be “underwriters” within the meaning of Section 2(a)(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on Metaany resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are “underwriters” within the meaning of Section 2(a)(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act.

To the extent required, the shares of our common stock. The Treasury Secretary has issued proposed regulations providing thatstock to be sold, the withholding provisions under FATCA do not applynames of the selling stockholders, the respective purchase prices and public offering prices, the names of any agents, dealer or underwriter, and any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the gross proceedsregistration statement that includes this prospectus.

In order to comply with the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered or qualified for sale or an exemption from registration or qualification requirements is available and is complied with.

We have advised the selling stockholders that the anti-manipulation rules of Regulation M under the Securities Exchange Act of 1934, as amended, may apply to sales of shares in the market and to the activities of the selling stockholders and their affiliates. In addition, to the extent applicable, we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the selling stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.

We have agreed to indemnify the selling stockholders against liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares offered by this prospectus.

Pursuant to the Acquisition Agreement, we have agreed with the selling stockholders to use best efforts to cause the registration statement of which this prospectus constitutes a part to be declared effective by the SEC as soon as practicable, and to keep the registration statement continuously effective under the Securities Act until the earlier of (1) such time as all of the shares covered by this prospectus have been sold by the selling stockholders or other disposition of Meta common stock, which(2) the date that all the shares covered by this prospectus may be relied uponsold by taxpayers until final regulations are issued. An intergovernmental agreement between the United Statesselling stockholders without volume or manner of sale restrictions pursuant to Rule 144, and your country of tax residence may modifywithout the requirements describedrequirement for the Company to be in this paragraph. If a dividend payment is both subject to withholdingcompliance with the current public information requirement under FATCA and subjectRule 144, as determined by counsel to the withholding tax discussed above under “Receipt of Distributions on Shares of Meta Common Stock,”Company pursuant to a written opinion to that effect, addressed and acceptable to the withholding under FATCA may be credited against,Company’s transfer agent and therefore reduce, such other withholding tax. Non-U.S. holders should consult their own tax advisors regarding the possible implications of FATCA on their investment in our common stock.selling stockholders.

THE PRECEDING DISCUSSION OF U.S. FEDERAL INCOME TAX CONSIDERATIONS IS FOR GENERAL INFORMATION ONLY AND IS NOT LEGAL OR TAX ADVICE. EACH HOLDER IS ENCOURAGED TO CONSULT ITS OWN TAX ADVISOR AS TO PARTICULAR TAX CONSEQUENCES RELATING TO THE ARRANGEMENT, INCLUDING THE APPLICABILITY AND EFFECT OF ANY U.S. FEDERAL, STATE, LOCAL OR FOREIGN TAX LAWS.

LEGAL MATTERS

Ballard Spahr LLP will pass upon the validity of the shares of common stock being offered hereby.

EXPERTS

The consolidated financial statements incorporated in this prospectus by reference from Meta Materials Inc.’sto the Company’s Annual Report on Form 10-K for the year ended December 31, 20202021, have been audited by Briggs & Veselka Co., which was ourKPMG LLP, the Company’s independent registered public accounting firm, for the year ended December 31, 2020, as statedset forth in itstheir report included in suchthereon, and incorporated herein by reference. Such consolidated financial statements and have been soare incorporated herein by reference in reliance upon thesuch report of such firm given upon its authority as experts in accounting and auditing. The financial statements of Metamaterial, Inc. incorporated in this prospectus by reference to our Current Report on Form 8-K/A filed with the SEC on August 17, 2021 have been so incorporated in reliance on the report of KPMG LLP, our independent registered public accounting firm, given on the authority of such firm as experts in auditingaccounting and accounting.auditing.

WHERE YOU CAN FIND MOREADDITIONAL INFORMATION

We are subject to the informational reporting requirements of the Securities Exchange Act of 1934, or Exchange Act. We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC’s web sitewebsite at http://www.sec.gov. You may also inspectwww.sec.gov.

We make available, free of charge, through our SECinvestor relations website, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, statements of changes in beneficial ownership of securities and amendments to those reports and statements and other information atas soon as reasonably practicable after they are filed with the SEC. The address for our web site atwebsite is http://www.metamaterial.com. We dowww.metamaterial.com. The contents on our website are not intend for information contained in our web site to be part of this prospectus, other than documentsand the reference to our website does not constitute incorporation by reference into this prospectus of the information contained at that site.

This prospectus is part of a registration statement we filed with the SEC. This prospectus omits some information contained in the registration statement in accordance with SEC rules and regulations. You should review the information and exhibits in the registration statement for further information about us and our consolidated subsidiaries and our securities. Statements in this prospectus concerning any document we filed as an exhibit to the registration statement or that we fileotherwise filed with the SEC that are incorporatednot intended to be comprehensive and are qualified by reference in this prospectus.to these filings. You should review the complete document to evaluate these statements. You can obtain a copy of the registration statement from the SEC’s website.

INCORPORATION OF CERTAIN INFORMATION WE INCORPORATE BY REFERENCE

The SEC allows us to “incorporate by reference” into this prospectus the documentsinformation we file with the SEC, whichSEC. This means that we can disclose important information to you by referring you to those documents. The informationAny statement contained in a document incorporated by reference is consideredin this prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein, or in any subsequently filed document, which also is incorporated by reference herein, modifies or supersedes such earlier statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.

We hereby incorporate by reference into this prospectus and informationthe following documents that we have filed with the SEC under the Exchange Act (other than current reports on Form 8-K, or portions thereof, furnished under Items 2.02 or 7.01 of Form 8-K):

our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March  2, 2022 and as amended on May 2, 2022;

our Quarterly Report on form 10-Q for the quarter ended March 31, 2022, filed with the SEC on May 10, 2022 and as amended on June 1, 2022;

our Current Report on Form 8-K filed with the SEC on April 6, 2022;

the description of our common stock contained inExhibit 4.6 to our Annual Report on Form 10-K filed with the SEC on March 2, 2022, including any amendment or report updating such description.

All documents that we file later with the SEC will automatically update and supersede information in this prospectus. We incorporate by reference the documents listed below and any future filings we will make with the SEC under Sectionspursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act other(other than any portions of the respective filings that were furnished, rather than filed, pursuant to Item 2.02 or Item 7.01 of Current Reportscurrent reports on Form 8-K, (including exhibits related thereto) or other applicable SEC rules, untilportions thereof, furnished under Items 2.02 or 7.01 of Form 8-K) (i) after the initial filing date of the registration statement of which this prospectus forms a part and prior to the effectiveness of such registration statement and (ii) after the date of this prospectus and prior to the termination of the offering of our securities under this registration statement is completed or withdrawn:

1. our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed on March 18, 2021;

2. our Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2021 and June 30, 2021, filed on May 14, 2021and August 13, 2021, respectively;

3. our Current Reports on Form 8-K as filed on January 6, 2021, January  13, 2021, January  14, 2021, January  22, 2021, January  25, 2021, January  28, 2021, January  29, 2021, February  1, 2021, February  4, 2021, February  8, 2021, February  10, 2021, February  16, 2021, February  22, 2021, March  11, 2021, March  15, 2021, April  1, 2021April  15, 2021, May  4, 2021, May  7, 2021, May  25, 2021, June  11, 2021, June  16, 2021, June  21, 2021, June  29, 2021, as amended on August  17, 2021, July  2, 2021, July  23, 2021, and August 10, 2021; and

4. the description of our common stock, par value $0.001 per share, contained in our registration statement on Form 8-A (Registration Statement No. 001-36247) filed with the SEC on December 13, 2013, including any amendment or report filed for the purpose of updating such description.

We also incorporateshall be deemed to be incorporated by reference eachin this prospectus from the date of filing of the documents, unless we specifically provide otherwise. Information that we file with the SEC under Sections 13(a), 13(c), 14will automatically update and may replace information previously filed with the SEC. To the extent that any information contained in any current report on Form 8-K or 15(d) of the Exchange Act until the offering of the common stock covered by this prospectus

terminates, including all such documents we may fileany exhibit thereto, was or is furnished to, rather than filed with the SEC, aftersuch information or exhibit is specifically not incorporated by reference.

Upon written or oral request made to us at the dateaddress or telephone number below, we will, at no cost to the requester, provide to each person, including any beneficial owner, to whom this prospectus is delivered, a copy of any or all of the initial registration statement and prior to the effectiveness of the registration statement. We will not, however, incorporateinformation that has been incorporated by reference in this prospectus any documents or portions thereof that are not deemed “filed” with the SEC, including any information furnished pursuant to Item 2.02 or Item 7.01 of our Current Reports on Form 8-K after the date of this prospectus unless, and except to the extent, specified in such Current Reports.

We will provide you with a copy of any of these filings (other than an exhibit to these filings,a filing, unless thethat exhibit is specifically incorporated by reference into that filing), but not delivered with this prospectus. You may also access this information on our website at https://www.metamaterial.com by viewing the filing requested) at no cost, if you submit a request“Financials & Filings” subsection of the “Investors” menu. No additional information on our website is deemed to usbe part of or incorporated by writing or telephoning us at the followingreference into this prospectus. We have included our website address and telephone number:in this prospectus solely as an inactive textual reference.

Meta Materials Inc.

1 Research Drive

Dartmouth, Nova Scotia B2Y 4M9

(902) 482-5729

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14. Other Expenses of Issuance and Distribution.Distribution

The following is a statement oftable sets forth the estimatedfees and expenses incurred or expected to be paid solelyincurred by the registrant, ofus in connection with the issuance and distribution of the securities being registered hereby:hereby, other than underwriting discounts and commissions.

 

Securities and Exchange Commission registration fee

  $46,653.08 

Printing expenses

   500.00 

SEC registration fee

  $1,650.66 

Legal fees and expenses

  $100,000 

Accounting fees and expenses

   10,000.00   $17,500 

Legal fees and expenses

   25,000.00 

Printing fees and engraving expenses

  $—   

Miscellaneous expenses

   5,000.00   $—   
  

 

   

 

 

Total

  $87,153.08   $119,150.66 
  

 

   

 

 

Item 15. Indemnification of Directors and Officers.Officers

Our Bylawsbylaws provide that we shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in our right, by reason of the fact that the person is or was our director, officer, employee or agent, or is or was serving at our request as a director, officer, employee or agent of another enterprise, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with the action, suit or proceeding if the person: (a) is not liable pursuant to Section 78.138 of the Nevada Revised Statutes (“NRS”); or (b) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to our best interests, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction or upon a plea of nolo contendere or its equivalent, does not, of itself, create a presumption that the person is liable pursuant to NRS 78.138 or did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to our best interests, or that, with respect to any criminal action or proceeding, he or she had reasonable cause to believe that the conduct was unlawful.

Our Bylawsbylaws also provide that we shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in our right to procure a judgment in our favor by reason of the fact that the person is or was our director, officer, employee or agent, or is or was serving at our request as a director, officer, employee or agent of another enterprise against expenses, including amounts paid in settlement and attorneys’ fees actually and reasonably incurred by the person in connection with the defense or settlement of the action or suit if the person: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to our best interests. Indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals therefrom, to be liable to us or for amounts paid in settlement to us, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.

Further, our Bylawsbylaws provide that the expenses of officers and directors incurred in defending a civil or criminal action, suit or proceeding must be paid by the Corporation as they are incurred and in advance of the final disposition of the action, suit or proceeding, upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately determined by a court of competent jurisdiction that the director or officer is not entitled to be indemnified by us.

II-1


Sections 78.7502 and 78.751 of the NRS permit the indemnifications described above. Further, Section 78.7502 provides that, to the extent that a director, officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to above, or in defense of any claim, issue or matter therein, we are required to indemnify him or her against expenses, including attorneys’ fees, actually and reasonably incurred by him or her in connection with the defense.

Item 16. Exhibits.Exhibits

See the Exhibit Index beginning on page II-6The following exhibits are filed as part of this registration statement, which is incorporated herein by reference.

Item 17. Undertakings.statement.

 

(a)

Incorporation by Reference

Exhibit
Number

The undersigned registrant hereby undertakes:Exhibit Description

Form

Filing

Date

Filed
Herewith

  3.1Articles of Incorporation10-K3/18/2019
  3.2Certificate of Amendment to Articles of Incorporation dated December 10, 2014.10-Q5/15/2015
  3.3Certificate of Amendment to Articles of Incorporation dated September 15, 2015.10-Q11/12/2015
  3.4Certificate of Amendment to Articles of Incorporation dated August 18, 2017.10-Q11/9/2018
  3.5Amendment to the Articles of Incorporation of Torchlight Energy Resources, Inc., dated June 14, 20218-K6/16/2021
  3.6Certificate of Amendment related to the Reverse Stock Split and Name Change, filed June 25, 20218-K6/29/2021
  3.7Amended and Restated Bylaws8-K10/26/2016
  3.8Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Preferred Stock, dated June 14, 2021, as modified by the Certificate of Correction, dated June 15, 2021.8-K6/16/2021
  3.9Certificate of Designation of Preferences, Rights and Limitations of Series B Special Voting Preferred Stock, dated June 14, 20218-K6/16/2021
  4.1Agreement for the Sale and Purchase of the Entire Issued Share Capital of Plasma App Ltd.10-Q/A6/1/2022
  5.1Opinion of Ballard Spahr LLPX
23.1Consent of KPMG LLP, independent registered public accounting firmX
23.2Consent of Ballard Spahr LLP (included in Exhibit 5.1)X
24.1Power of Attorney (included on the signature page to this Registration Statement)X
107Filing Fee TableX

Item 17. Undertakings

(1)

To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(a) The undersigned registrant hereby undertakes;

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement;

(i) To include any prospectus required by sectionSection 10(a)(3) of the Securities Act of 1933;

II-2


(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20%20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement.statement; and

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;provided,

Provided, however,, that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.statement;

(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof;

(2)

That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering;

(3)

To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

(4)

That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

(i)(A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

(ii)(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by sectionSection 10(a) of

the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which thatthe prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.date; and

(5)

That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this(5) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the securities offered therein, and the offering requiredof such securities at that time shall be deemed to be filedthe initial bona fide offering thereof.

II-3


(6) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to Rule 424;

(ii) Any free writing prospectus relating to the offering prepared byforegoing provisions, or on behalfotherwise, the registrant has been advised that in the opinion of the undersigned registrant or used or referred toSecurities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the undersigned registrant;

(iii) The portionregistrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any other free writing prospectus relating toaction, suit or proceeding) is asserted by such director, officer or controlling person in connection with the offering containing material information aboutsecurities being registered, the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

(iv) Any other communication that is an offerwill, unless in the offering madeopinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the undersigned registrant to the purchaser.final adjudication of such issue.

 

(6)

The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

II-4

(7)

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Dartmouth, Province of Nova Scotia, Country of Canada, on the 25 day of August, 2021.June 2, 2022.

 

 Meta Materials Inc.META MATERIALS INC.
Date: August 25, 2021By: /s/ George Palikaras
 George Palikaras
 President and Chief Executive Officer

Power of Attorney

SIGNATURE PAGE AND POWER OF ATTORNEY

We the undersigned officersKNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and directors of Meta Materials Inc., hereby, severally constitute and appointappoints George Palikaras and Kenneth L, Rice, each of them singly, our true and lawful attorneys with full power to them and each of them singly,acting individually, as his or her true and lawful attorneys-in-fact and agent, with full power of each to signact alone, with full powers of substitution and resubstitution, for ushim or her and in our nameshis or her name, place and stead, in the capacities indicated below, the registration statement on Form S-3 filed herewith and any and all pre-effectivecapacities, to sign any and all amendments to this registration statement (including post-effective amendments to said registration statement and any subsequentrelated registration statement forstatements filed pursuant to Rule 462 and otherwise), and to file the same offering which may be filed under Rule 462(b)with all exhibits thereto, and generally to do all such thingsother documents in our names and on our behalf in our capacities as officers and directors to enable Meta Materials Inc. to complyconnection therewith, with the provisions of the Securities Act of 1933, and all requirements of the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming our signatures as they may be signed by ourthat all said attorneys,attorneys-in-fact and agents, or any of them or their substitute or resubstitute, may lawfully do or cause to said registration statement and any and all amendments thereto or to any subsequent registration statement for the same offering which may be filed under Rule 462(b).done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ George Palikaras

George Palikaras

  Director,

President, Chief Executive Officer and President (PrincipalDirector

(Principal Executive Officer)

August 25, 2021

/s/ Ramamritham Ramkumar

Ramamritham Ramkumar

 Director (Chairman of the Board))June 2, 2022August 25, 2021

/s/ Kenneth L. Rice

Kenneth L. Rice

  Chief Operating Officer and Chief Financial Officer Executive Vice President and Secretary (Principal Financial and Accounting Officer) August 25, 2021June 2, 2022

/s/ Maurice Guitton

Maurice Guitton

  Director August 25, 2021

/s/ Allison Christilaw

Allison Christilaw

DirectorAugust 25, 2021

/s/ Steen Karsbo

Steen Karsbo

DirectorAugust 25, 2021June 2, 2022

/s/ Eric M. Leslie

Eric M. Leslie

  Director August 25, 2021June 2, 2022

/s/ Ramamritham Ramkumar

Ramamritham Ramkumar

DirectorJune 2, 2022

II-5


SignatureTitleDate

/s/ Allison Christilaw

Allison Christilaw

DirectorJune 2, 2022

/s/ Steen Karsbo

Steen Karsbo

DirectorJune 2, 2022

/s/ Kenneth Hannah

Kenneth Hannah

  Director August 25, 2021

EXHIBIT INDEX

Exhibit
Number

Description

  2.1Arrangement Agreement with Metamaterial Inc., dated December  14, 2020. (the “Arrangement Agreement”) (Incorporated by reference from Form 8-K filed with the SEC on December 14, 2020.)
  2.2Amendment to Arrangement Agreement, dated February  3, 2021 (Incorporated by reference from Form 8-K filed with the SEC on February 4, 2021.)
  2.3Amendment to Arrangement Agreement, dated March  11, 2021 (Incorporated by reference from Form 8-K filed with the SEC on March 15, 2021.)
  2.4Amendment to Arrangement Agreement, dated March  31, 2021. (Incorporated by reference from Form 8-K filed with the SEC on April 1, 2021.)
  2.5Amendment to Arrangement Agreement, dated April  15, 2021. (Incorporated by reference from Form 8-K filed with the SEC on April 15, 2021.)
  2.6Amendment to Arrangement Agreement, dated MayJune 2, 2021. (Incorporated by reference from Form  8-K filed with the SEC on May 4, 2021, 2021.)
  2.7Amendment to Arrangement Agreement, dated June 18, 2021. (Incorporated by reference from Form  8-K filed with the SEC on June 21, 2021.)
  3.1Articles of Incorporation. (Incorporated by reference from Form 10-K filed with the SEC on March 18, 2019)
  3.2Certificate of Amendment to Articles of Incorporation dated December 10, 2014. (Incorporated by reference from Form 10-Q filed with the SEC on May 15, 2015.)
  3.3Certificate of Amendment to Articles of Incorporation dated September 15, 2015. (Incorporated by reference from Form 10-Q filed with the SEC on November 12, 2015.)
  3.4Certificate of Amendment to Articles of Incorporation dated August 18, 2017. (Incorporated by reference from Form 10-Q filed with the SEC on August 9, 2018.)
  3.5Certificate of Amendment to Articles of Incorporation dated June 14, 2021. (Incorporated by reference from Form 8-K filed with the SEC on June 16, 2021.)
  3.6Certificate of Amendment to Articles of Incorporation dated June 25, 2021. (Incorporated by reference from Form 8-K filed with the SEC on June 29, 2021.)
  3.7Amended and Restated Bylaws. (Incorporated by reference from Form 8-K filed with the SEC on October 26, 2016.)
  5.1^Opinion of Ballard Spahr LLP with respect to the legality of the securities registered hereunder.
23.1*Consent of Briggs & Veselka Co.
23.2*Consent of KPMG LLP
23.3^Consent of Ballard Spahr LLP (included in Exhibit 5.1)
24.1*Power of Attorney (set forth on the signature pages to this registration statement)

*

Filed herewith.

^

Previously filed.

2022

 

20II-6